New unemployment filings in Maryland fell significantly last week, offering a spot of positive news for the state's labor market as national claims also edged lower.
Corebridge Financial (CRBG) has launched a novel index annuity linked to the Invesco New Economy Index, offering exposure to tech themes and Bitcoin. The move comes as analysts debate whether the company's current share price fully reflects its growth potential amid mixed recent performance.
As artificial intelligence reshapes finance, we examine whether XRP's underlying technology is built to capitalize on the trend of 'agentic AI' handling transactions, or if its potential benefits remain speculative.
After a sharp January sell-off, Shopify's stock is hovering near a significant long-term trendline—a level that has preceded notable rallies in the past.
The payments giant reported a 15% jump in revenue, beating Wall Street estimates, as it positions itself to capitalize on emerging trends in stablecoins and AI-driven commerce.
Chicago's downtown office vacancy rate soared to a historic 28.2% at the close of 2025, more than double pre-pandemic levels, as remote work trends and business climate concerns drive a 14th consecutive quarter of record vacancies. Analysts warn of a deepening economic spiral with implications for city services and residents.
As United Parcel Service executes a strategic overhaul focused on profitability over volume, its financials reveal a nascent but promising trend, leading some investors to see a potential rebound on the horizon despite recent stock declines.
Conagra Brands launches its protein-packed Banquet MEGA Breakfast Bowls, a direct challenge to rivals in the frozen aisle. While the move aligns with consumer trends, analysts question if it's enough to offset broader financial pressures facing the packaged food giant.
Barclays initiates coverage of 4D Molecular Therapeutics with an Overweight rating and a $33 price target, citing a favorable industry backdrop with potential M&A tailwinds and shifting focus away from drug pricing pressures. The gene therapy developer also outlined key clinical milestones expected through 2026.
Amphenol Corporation (NYSE: APH), a key player in electronic connectors, received concurrent price target increases from Seaport Research and Citi. While analysts highlight growth potential, the stock's post-earnings dip underscores a cautious market stance toward the company's traditionally conservative guidance.
Amid a quarter dominated by mega-cap tech and AI fervor, Pzena Investment Management's value-focused fund highlighted discount retailer Dollar General as a key performer, driven by strong earnings that propelled its stock.
Revvity (NYSE: RVTY) surged past fourth-quarter expectations and issued an upbeat 2026 outlook, driven by robust demand in its diagnostics division. The medical equipment maker's performance highlights a sector-wide resilience despite ongoing softness in academic research funding.
Northland Power Inc. (TSE:NPI) is showing signs of strain as its return on capital employed (ROCE) has trended downward over the past five years. While still above the renewable energy sector average, the declining efficiency and stagnant capital base signal potential challenges for the independent power producer's growth trajectory.
While analyst price targets often paint a rosy picture, a deeper look reveals which recommendations are backed by solid business trends and which may be overly optimistic. We examine one fintech disruptor and one industrial stalwart favored by the Street, alongside a retailer facing significant headwinds.
Footwear and accessories distributor Weyco Group is demonstrating a compelling financial trend: improving returns on its invested capital alongside increased reinvestment. This dual engine, analysts note, is a classic hallmark of companies capable of compounding value over time.
While LKQ's stock has mirrored the broader market's gains, a deeper look at its core fundamentals reveals concerning trends in organic revenue, cash flow stability, and returns on capital, prompting some investors to seek growth elsewhere.
As several stocks test their 52-week highs, we separate resilient momentum from potential mirages. We analyze one company capitalizing on long-term trends and two where caution may be warranted.
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing expansion for its weight-loss drugs and enters two strategic research collaborations in gene editing and immunology, signaling aggressive growth plans amid a recent stock valuation dip.
An analysis of Mooreast Holdings' financial metrics reveals a worrying trend of declining returns on capital employed, despite growth in its asset base. The company's performance lags behind its own historical figures, prompting a closer look from the market.
Realtor.com ranks the Florida Keys among the nation's top luxury markets, where strict development limits and finite land create a high-stakes arena for elite buyers seeking a unique legacy, not just a second home.
